Standex International Corporation (SXI) Stock Analysis
Is SXI a good investment?
Standex International Corporation (SXI) has a Plutrex AI rating of 71.0/100 as of November 10, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: PEG ratio of 1.29 represents a ~50% discount to the industry average of 2.56, combined with forward EPS growth of 20.5% (117% above the industry average of 9.4%) — SXI is the most attractively priced high-growth name in the Industrial Machinery peer group on a growth-adjusted basis. Main concern: Revenue growth of 7.0%, while improved from 2.8%, is still 51.9% below the industry average of 14.55% — sustaining 20%+ EPS growth with only 7% top-line growth requires continuous margin expansion, mix improvement, or buyback execution; any single quarter of margin compression would expose the EPS growth gap.
Investment Summary
Standex International (SXI) at $247.47 is a high-quality industrial compounder with genuinely exceptional forward EPS growth (20.5% next year, 20.4% five-year) trading at a PEG of 1.29 — roughly 50% below the industry average PEG of 2.56. The latest Q1 FY2027 results confirm operational momentum: record adjusted gross margin of 44.4% (up 240bps YoY), FY2026 revenue of $891.6M, and net profit nearly doubling to $104.8M. The 249th consecutive quarterly dividend underscores financial discipline. However, structural concerns remain: revenue growth of 7.0% (vs. industry 14.55%) requires sustained margin expansion to deliver 20%+ EPS growth; ROE of 15.3% is 32% below the industry average of 22.69%; and D/E of 0.71 is elevated vs. peers (0.56 average). The stock has risen modestly (+2.3%) from the prior report's midpoint, keeping it at the upper bound of the prior entry range ($228-$245). With no analyst consensus target available and the stock sitting above the prior entry zone, the risk/reward is slightly less compelling than 14 days ago but the fundamental trajectory has improved (revenue growth accelerated from 2.8% to 7.0%, PEG compressed from 1.78 to 1.29). Net verdict: Weak Buy, maintaining prior stance with entry zone trimmed to below-current levels to reflect modest price appreciation.
Key Strengths
- PEG ratio of 1.29 represents a ~50% discount to the industry average of 2.56, combined with forward EPS growth of 20.5% (117% above the industry average of 9.4%) — SXI is the most attractively priced high-growth name in the Industrial Machinery peer group on a growth-adjusted basis
- Record adjusted gross margin of 44.4% in Q1 FY2027 (up 240bps YoY per earnings release), with FY2026 net profit nearly doubling to $104.8M — operational execution is accelerating, not just projecting forward growth; Electronics segment's 29.5% organic growth reflects secular exposure to EV/defense/automation
- 249th consecutive quarterly dividend (per headline 'STANDEX DECLARES 249th CONSECUTIVE QUARTERLY DIVIDEND') with a 5.9% dividend hike demonstrates capital return discipline and financial health consistency spanning six decades of uninterrupted payments
Key Concerns
- Revenue growth of 7.0%, while improved from 2.8%, is still 51.9% below the industry average of 14.55% — sustaining 20%+ EPS growth with only 7% top-line growth requires continuous margin expansion, mix improvement, or buyback execution; any single quarter of margin compression would expose the EPS growth gap
- ROE of 15.3% is 32.4% below the industry average of 22.69% while D/E of 0.71 is 26.6% above peers (0.56 average) — SXI takes above-average balance sheet risk to generate below-average equity returns; at P/B of 3.85x, a deterioration in ROE would create significant multiple compression risk with no analyst consensus target to provide a floor
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
Profitability is SXI's standout pillar: gross margin 42.3% (vs. industry 32.8%, +28.9% premium) confirms genuine product differentiation in sensors, magnetics, and engineered components. Operating margin 18.4% (vs. industry 16.5%, +11.3% premium) shows disciplined cost control. Net margin 12.5% (vs. industry 12.6%) converges at the net line due to higher interest expense from D/E of 0.71 (vs. industry 0.56). ROE of 15.3% is notably below the industry average of 22.69% — SXI uses more leverage than peers but generates less equity return, a persistent capital efficiency gap. Forward EPS growth of 20.5% (1-year) and 20.4% (5-year) dwarf the industry average of 9.4% and 15.2% respectively, making SXI the clear growth leader in its peer group. Revenue growth of 7.0% materially improved from 2.8% in the prior report — a significant positive development — but still lags the industry at 14.55%. P/E of 26.3x (vs. peers 24.6x) is a modest 6.8% premium justified by the growth advantage. PEG of 1.29 (vs. peers 2.56) is the most compelling relative value signal. Cash of $121.8M and FCF of $48.9M provide adequate liquidity. Debt is manageable but limits balance sheet flexibility. The P/B of 3.85x requires sustained ROE above cost of capital to justify, which at 15.3% is achievable but not wide-margin compelling.
News Sentiment
Standex International is quietly doing something impressive — and Wall Street is finally starting to notice. The Connecticut-based industrial manufacturer just reported Q1 fiscal 2027 results that beat both earnings and revenue estimates, sending a clear signal that the company's transformation story is real, not just projected. The headline numbers are striking: fiscal year 2026 revenue hit $891.6 million, and net profit nearly doubled to $104.8 million, a remarkable achievement for a 100-year-old industrial company. The Q1 FY2027 earnings call transcript and financial results press release revealed record adjusted gross margins of 44.4% — up 240 basis points year-over-year — meaning Standex is squeezing more profit from every dollar of revenue than at any point in its history. The company's Electronics segment, growing at 29.5% organically, is riding secular tailwinds in electric vehicles, defense electronics, and industrial automation — markets expected to grow for a decade. Perhaps most telling for income investors: Standex just declared its 249th consecutive quarterly dividend, a streak stretching back more than 60 years through recessions, financial crises, and pandemics. This kind of consistency is rare in any industry. With earnings beating estimates and margins expanding, Standex appears to be earning its valuation premium — the question for new investors is simply whether to wait for a pullback or start building a position at current levels near $247.
Risk Assessment
PRIMARY RISK: EPS growth disappointment — if 20.5% forward EPS growth fails to materialize (driven by margin compression or volume weakness), the P/E of 26.3x with a 7% revenue grower has limited multiple support; a reversion to 20x P/E on flat earnings implies ~24% downside to ~$188. SECONDARY RISK: ROE gap vs. peers (15.3% vs. 22.69%) — if capital allocation remains suboptimal and ROE fails to expand toward 20%, the P/B of 3.85x becomes increasingly hard to defend. TERTIARY RISK: Revenue growth lag — industry growing at 14.55% while SXI at 7.0% suggests potential market share pressure or more commodity-like volume exposure despite premium margins. MITIGATION: Stop at $218 (8.1% below entry midpoint of $240) limits downside; FCF of $48.9M and 249-consecutive-quarter dividend history provide fundamental floor; gross margin expansion trend (44.4% in Q1 FY2027 vs. 42.3% trailing) partially addresses the revenue growth gap concern. No analyst consensus target limits upside validation.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is SXI a halal stock?
No, Standex International Corporation (SXI) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for SXI?
Standex International Corporation (SXI) has a Plutrex AI rating of 71.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is SXI a good investment?
According to Plutrex AI, SXI has a Buy rating (71.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in SXI?
US stocks like SXI can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in SXI?
Plutrex AI identifies the main risks for SXI by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.